Rocket Lab USA Inc (NASDAQ:RKLB) shares traded 11.64% higher at $30.60 on Wall Street last session.
RKLB stock price is now 15.74% away from the 50-day moving average and 151.18% away from the 200-day moving average. The market capitalization of the company currently stands at $15.30B.
On July 15, 2024, Morgan Stanley Downgraded its previous ‘Overweight’ rating to ‘Equal-Weight’ on the stock reducing its target price from $8 to quote $6, while ‘BTIG Research’ rates the stock as ‘Neutral’
In other news, Armagno Nina, Director sold 10,000 shares of the company’s stock on Dec 11 ’24. The stock was sold for $236,345 at an average price of $23.63. Upon completion of the transaction, the Director now directly owns 132,294 shares in the company, valued at $4.05 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 11 ’24, Director NINA ARMAGNO bought 10,000 shares of the business’s stock. A total of $236,345 was incurred on buying the stock at an average price of $23.63. A total of 24.30% of the company’s stock is owned by insiders.
During the past 12 months, Rocket Lab USA Inc has had a low of $3.47 and a high of $33.34. As of last week, the company has a debt-to-equity ratio of 1.12, a current ratio of 2.58, and a quick ratio of 2.16. The fifty day moving average price for RKLB is $26.3083 and a two-hundred day moving average price translates $12.048 for the stock.
The latest earnings results from Rocket Lab USA Inc (NASDAQ: RKLB) was released for 2024-09-30. The net profit margin was -51.76% and return on equity was -37.45% for RKLB. The company reported revenue of $104.81 million for the quarter, compared to $67.66 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 54.9 percent. For the current quarter, analysts expect RKLB to generate $130.57M in revenue.